Integrated cancer cell-specific single-cell RNA-seq datasets of immune checkpoint blockade-treated patients
Scientific Data,
Journal Year:
2025,
Volume and Issue:
12(1)
Published: Jan. 22, 2025
Abstract
Immune
checkpoint
blockade
(ICB)
therapies
have
emerged
as
a
promising
avenue
for
the
treatment
of
various
cancers.
Despite
their
success,
efficacy
these
treatments
is
variable
across
patients
and
cancer
types.
Numerous
single-cell
RNA-sequencing
(scRNA-seq)
studies
been
conducted
to
unravel
cell-specific
responses
ICB
treatment.
However,
are
limited
in
sample
sizes
require
advanced
coding
skills
exploration.
Here,
we
compiled
eight
scRNA-seq
datasets
from
nine
types,
encompassing
223
patients,
90,270
cells,
265,671
other
cell
This
compilation
forms
unique
resource
tailored
investigate
how
cells
respond
We
meticulously
curated,
quality-checked,
pre-processed,
analyzed
data,
ensuring
easy
access
researchers.
Moreover,
designed
user-friendly
interface
seamless
By
sharing
code
data
creating
interfaces,
aim
assist
fellow
These
resources
offer
valuable
support
those
interested
leveraging
exploring
diverse
facilitating
comprehensive
understanding
responses.
Language: Английский
Identification of cancer cell-intrinsic biomarkers associated with tumor progression and characterization of SFTA3 as a tumor suppressor in lung adenocarcinomas
BMC Cancer,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Jan. 8, 2025
Recent
advancements
in
contemporary
therapeutic
approaches
have
increased
the
survival
rates
of
lung
cancer
patients;
however,
long-term
benefits
remain
constrained,
underscoring
pressing
need
for
novel
biomarkers.
Surfactant-associated
3
(SFTA3),
a
long
non-coding
RNA
predominantly
expressed
normal
epithelial
cells,
plays
crucial
role
development.
Nevertheless,
its
function
adenocarcinoma
(LUAD)
remains
inadequately
understood.
Single-cell
sequencing
data
were
utilized
to
identify
cell-intrinsic
gene
signatures
associated
with
progression
LUAD,
and
their
roles
LUAD
comprehensively
analyzed.
Serum
samples
collected
quantify
expression
levels
SFTA3
patients.
Furthermore,
series
biological
experiments,
including
cell
viability
assays,
scratch
wound
healing
colony
formation
conducted
demonstrate
tumor-suppressive
effects
SFTA3.
was
performed
elucidate
molecular
mechanisms
underlying
cells.
We
constructed
prognostic
model
comprising
eight
genes:
ALDOA,
ATP5MD,
SERPINH1,
SFTA3,
SLK,
U2SURP,
SCGB1A1,
SCGB1A3.
The
effectively
stratified
patients
into
high-
low-risk
categories,
revealing
that
experienced
superior
clinical
outcomes,
exhibited
an
immunologically
hot
tumor
microenvironment
(TME),
had
greater
probability
responding
immunotherapy.
In
contrast,
high-risk
group
cold
TME
may
benefit
more
from
chemotherapy.
our
study
revealed
progressive
decrease
cells
correlated
advancement.
Notably,
serum
significantly
decreased
suggesting
potential
utility
liquid
biopsy
diagnosis.
Additionally,
knockdown
enhances
proliferation
migration
whereas
overexpression
inhibits
these
phenotypes.
epithelial-mesenchymal
transition
pathway
enriched
following
silencing,
impact
by
modulating
this
process.
also
identified
key
transcription
factors
epigenetic
implicated
downregulation
LUAD.
developed
robust
as
biomarker
applications
diagnosis,
prognosis,
personalized
treatment
findings
offer
new
insights
tumorigenesis
immune
evasion.
Language: Английский
Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(2), P. e0309880 - e0309880
Published: Feb. 10, 2025
The
continuous
threats
posed
by
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2),
the
virus
that
causes
COVID-19,
including
emergence
of
potentially
more
infectious
and
deadly
variants,
necessitate
ongoing
studies
to
uncover
novel
detailed
mechanisms
driving
disease
severity.
Using
single-cell
transcriptomics,
we
conducted
a
secondary
data
analysis
bronchoalveolar
lavage
fluid
(BALF)
from
COVID-19
patients
varying
severities
healthy
controls
comprehensively
examine
immune
responses.
We
observed
significant
cell
alterations
correlating
with
In
severe
cases,
macrophages
showed
upregulation
pro-inflammatory
genes
TNFα
IL1β,
contributing
inflammation
tissue
damage.
Neutrophils
exhibited
increased
activation,
marked
S100A8,
CXCL8,
IL1β
expression,
extended
viability
reduced
phagocytosis.
Genes
such
as
MCL1
HIF1α
supported
viability,
while
MSR1
MRC1
indicated
Enhanced
formation
neutrophil
extracellular
traps
(NETs)
clearance,
NET-associated
markers,
were
linked
thrombo-inflammation
organ
Both
neutrophils
in
cases
impaired
efferocytosis,
decreased
expression
TREM2
downregulation
FCGR3B
neutrophils,
leading
accumulation
apoptotic
cells
exacerbating
inflammation.
characterized
M1
high
milder
had
M2
elevated
PPARγ.
Dendritic
(DCs)
proportions
attenuated
MHC
class
I
(HLA-A,
HLA-B,
HLA-C)
co-stimulatory
molecules
(CD80,
CD86),
alongside
cytochrome
c
indicating
antigen
presentation
enhanced
apoptosis.
NK
T
demonstrated
altered
receptor
gene
activation
markers
IFNγ
ISG15,
suggesting
paradoxical
state
exhaustion.
This
highlights
critical
role
dysregulated
neutrophil,
macrophage,
dendritic
cell,
NK,
responses
identifying
potential
therapeutic
targets
providing
insights
into
disease.
Language: Английский
Single-Cell Transcriptomic Approaches for Decoding Non-Coding RNA Mechanisms in Colorectal Cancer
Non-Coding RNA,
Journal Year:
2025,
Volume and Issue:
11(2), P. 24 - 24
Published: March 10, 2025
Non-coding
RNAs
(ncRNAs)
play
crucial
roles
in
colorectal
cancer
(CRC)
development
and
progression.
Recent
developments
single-cell
transcriptome
profiling
methods
have
revealed
surprising
levels
of
expression
variability
among
seemingly
homogeneous
cells,
suggesting
the
existence
many
more
cell
types
than
previously
estimated.
This
review
synthesizes
recent
advances
ncRNA
research
CRC,
emphasizing
bioinformatics
approaches
for
their
analysis.
We
explore
computational
tools
used
identification,
characterization,
functional
prediction
with
a
focus
on
RNA
sequencing
(scRNA-seq)
data.
The
highlights
key
strategies,
including
sequence-based
structure-based
approaches,
machine
learning
applications,
multi-omics
data
integration.
discuss
how
these
techniques
can
be
applied
to
analyze
differential
expression,
perform
enrichment,
construct
regulatory
networks
involving
ncRNAs
CRC.
Additionally,
we
examine
role
leveraging
as
diagnostic
prognostic
biomarkers
also
scRNA-seq
studies
revealing
heterogeneity
aims
provide
comprehensive
overview
current
state
CRC
outline
future
directions
this
rapidly
evolving
field,
integration
experimental
validation
advance
our
understanding
biology
Language: Английский
RNA-based diagnostic innovations: A new frontier in diabetes diagnosis and management
Esther Ugo Alum,
No information about this author
Ernest Nnamdi Ikpozu,
No information about this author
Christian Emeka Offor
No information about this author
et al.
Diabetes and Vascular Disease Research,
Journal Year:
2025,
Volume and Issue:
22(2)
Published: March 1, 2025
Background/Objective:
Diabetes
mellitus
(DM)
remains
a
major
global
health
challenge
due
to
its
chronic
nature
and
associated
complications.
Traditional
diagnostic
approaches,
though
effective,
often
lack
the
sensitivity
required
for
early-stage
detection.
Recent
advancements
in
molecular
biology
have
identified
RNA
molecules,
particularly
non-coding
RNAs
such
as
microRNAs
(miRNAs),
long
(lncRNAs),
circular
(circRNAs),
promising
biomarkers
diabetes.
This
review
aims
explore
role
of
RNA-based
diagnosis,
prognosis,
management
diabetes,
highlighting
their
potential
revolutionize
diabetes
care.
Method:
A
comprehensive
literature
was
conducted
using
electronic
databases
including
PubMed,
Scopus,
Web
Science.
Articles
published
up
2024
were
screened
analyzed
extract
relevant
findings
related
diagnostics
Emphasis
placed
on
studies
demonstrating
clinical
utility,
mechanistic
insights,
translational
molecules.
Results:
Numerous
species,
miRNAs
miR-375,
miR-29,
lncRNAs
like
H19
MEG3,
exhibit
altered
expression
patterns
diabetic
patients.
These
molecules
are
involved
key
regulatory
pathways
glucose
metabolism,
insulin
resistance,
β-cell
function.
Circulating
detectable
various
biofluids,
enabling
non-invasive
approaches.
Emerging
technologies,
sequencing
liquid
biopsy
platforms,
enhanced
specificity
detection,
fostering
development
novel
tools
personalized
therapeutic
strategies.
Conclusion:
hold
significant
promise
advancing
early
risk
stratification,
monitoring
Despite
current
challenges
standardization
validation,
integration
into
routine
practice
could
transform
management,
paving
way
precision
medicine
Further
research
multi-center
trials
essential
validate
these
facilitate
approval
implementation.
Language: Английский
Bronchoalveolar Lavage Single-Cell Transcriptomics Identifies Immune Cells Driving COVID-19 Severity in Patients
Njinju Asaba Clinton,
No information about this author
Razieh Bitazar,
No information about this author
Patrick Ndonyi Labonté
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 23, 2024
The
continuous
threats
posed
by
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2),
the
virus
that
causes
COVID-19,
including
emergence
of
potentially
more
infectious
and
deadly
variants,
necessitate
ongoing
studies
to
uncover
novel
detailed
mechanisms
driving
disease
severity.
Using
single-cell
transcriptomics,
we
conducted
a
secondary
data
analysis
bronchoalveolar
lavage
fluid
(BALF)
from
COVID-19
patients
varying
severities
healthy
controls
comprehensively
examine
immune
responses.
We
observed
significant
cell
alterations
correlating
with
In
severe
cases,
macrophages
showed
upregulation
pro-inflammatory
genes
TNFα
IL1β,
contributing
inflammation
tissue
damage.
Neutrophils
exhibited
increased
activation,
marked
S100A8,
CXCL8,
IL1β
expression,
extended
viability
reduced
phagocytosis.
Genes
such
as
MCL1
HIF1α
supported
viability,
while
MSR1
MRC1
indicated
Enhanced
formation
neutrophil
extracellular
traps
(NETs)
clearance,
NET-associated
markers,
were
linked
thrombo-inflammation
organ
Both
neutrophils
in
cases
impaired
efferocytosis,
decreased
expression
TREM2
downregulation
FCGR3B
neutrophils,
leading
accumulation
apoptotic
cells
exacerbating
inflammation.
characterized
M1
high
milder
had
M2
elevated
PPARγ.
Low-density
(LDNs)
significantly
showing
higher
CXCR4
CD274
lower
compared
high-density
(HDNs).
NK
T
demonstrated
altered
receptor
gene
activation
markers
IFNγ
ISG15,
suggesting
paradoxical
state
exhaustion.
This
imbalance
suggests
potential
mechanism
for
dysregulation
ineffective
antiviral
responses
COVID-19.
highlights
critical
role
dysregulated
neutrophil,
macrophage,
NK,
identifying
therapeutic
targets
providing
insights
into
disease.
Language: Английский